Clinical Trial Update: Exploratory Study of OMS302 Injection in Subjects Undergoing Unilateral Cataract Extraction by Phacoemulsification. [Phase 1, Phase 2]

View source ↗

Summary

This document reports the completion of an exploratory Phase 1/2 study evaluating OMS302 injections in adults undergoing unilateral cataract extraction by phaco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• OMS302

Snippet

Sponsor: Omeros Corporation | Conditions: Cataract Extraction | Phase 1, Phase 2 | Status: COMPLETED